Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
Charles N Serhan, Rong Yang, Kimberly Martinod, Kie Kasuga, Padmini S Pillai, Timothy F Porter, Sungwhan F Oh, Matthew Spite, Charles N Serhan, Rong Yang, Kimberly Martinod, Kie Kasuga, Padmini S Pillai, Timothy F Porter, Sungwhan F Oh, Matthew Spite
Abstract
The endogenous cellular and molecular mechanisms that control acute inflammation and its resolution are of wide interest. Using self-resolving inflammatory exudates and lipidomics, we have identified a new pathway involving biosynthesis of potent antiinflammatory and proresolving mediators from the essential fatty acid docosahexaenoic acid (DHA) by macrophages (MPhis). During the resolution of mouse peritonitis, exudates accumulated both 17-hydroxydocosahexaenoic acid, a known marker of 17S-D series resolvin (Rv) and protectin biosynthesis, and 14S-hydroxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid from endogenous DHA. Addition of either DHA or 14S-hydroperoxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid to activated MPhis converted these substrates to novel dihydroxy-containing products that possessed potent antiinflammatory and proresolving activity with a potency similar to resolvin E1, 5S,12R,18R-trihydroxyeicosa-6Z,8E,10E,14Z,16E-pentaenoic acid, and protectin D1, 10R,17S-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid. Stable isotope incorporation, intermediate trapping, and characterization of physical and biological properties of the products demonstrated a novel 14-lipoxygenase pathway, generating bioactive 7,14-dihydroxydocosa-4Z,8,10,12,16Z,19Z-hexaenoic acid, coined MPhi mediator in resolving inflammation (maresin), which enhances resolution. These findings suggest that maresins and this new metabolome may be involved in some of the beneficial actions of DHA and MPhis in tissue homeostasis, inflammation resolution, wound healing, and host defense.
Figures
References
- Nathan, C. 2002. Points of control in inflammation. Nature. 420:846–852.
- Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 220:568–575.
- Gilroy, D.W., T. Lawrence, M. Perretti, and A.G. Rossi. 2004. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3:401–416.
- Serhan, C.N., N. Chiang, and T.E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8:349–361.
- Serhan, C.N., C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2–nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192:1197–1204.
- Serhan, C.N., S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.-L. Moussignac. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196:1025–1037.
- Hong, S., K. Gronert, P. Devchand, R.-L. Moussignac, and C.N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278:14677–14687.
- Bannenberg, G.L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K.H. Gotlinger, S. Hong, and C.N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174:4345–4355.
- Cotran, R.S., V. Kumar, and T. Collins, editors. 1999. Robbins Pathologic Basis of Disease. W.B. Saunders Co., Philadelphia. 1425 pp.
- Calder, P.C. 2007. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids. 77:327–335.
- Simopoulos, A.P. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21:495–505.
- Orr, S.K., and R.P. Bazinet. 2008. The emerging role of docosahexaenoic acid in neuroinflammation. Curr. Opin. Investig. Drugs. 9:735–743.
- Schwab, J.M., N. Chiang, M. Arita, and C.N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 447:869–874.
- Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan. 2005. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201:713–722.
- Cash, J.L., R. Hart, A. Russ, J.P.C. Dixon, W.H. Colledge, J. Doran, A.G. Hendrick, M.B.L. Carlton, and D.R. Greaves. 2008. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205:767–775.
- Hudert, C.A., K.H. Weylandt, J. Wang, Y. Lu, S. Hong, A. Dignass, C.N. Serhan, and J.X. Kang. 2006. Transgenic mice rich in endogenous n-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA. 103:11276–11281.
- Gronert, K., N. Maheshwari, N. Khan, I.R. Hassan, M. Dunn, and M.L. Schwartzman. 2005. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280:15267–15278.
- Merched, A., K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan. 2008. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22:3595–3606.
- Winyard, P.G., and D.A. Willoughby, editors. 2003. Inflammation Protocols. Humana, Totowa, NJ. 378 pp.
- Serhan, C.N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S.P. Colgan, and N.A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176:1848–1859.
- Mukherjee, P.K., V.L. Marcheselli, C.N. Serhan, and N.G. Bazan. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 101:8491–8496.
- Fox, M.A., and J.K. Whitesell. 1997. Organic Chemistry. Jones and Bartlett Publishers, Boston. 1248 pp.
- Godson, C., S. Mitchell, K. Harvey, N.A. Petasis, N. Hogg, and H.R. Brady. 2000. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:1663–1667.
- Rossi, A.G., J.C. McCutcheon, N. Roy, E.R. Chilvers, C. Haslett, and I. Dransfield. 1998. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J. Immunol. 160:3562–3568.
- German, J.B., G.G. Bruckner, and J.E. Kinsella. 1986. Lipoxygenase in trout gill tissue acting on arachidonic, eicosapentaenoic and docosahexaenoic acids. Biochim. Biophys. Acta. 875:12–20.
- Lagarde, M., M. Croset, M. Guichardant, and M. Dechavanne. 1985. Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv. Exp. Med. Biol. 192:327–335.
- Kim, H.Y., J.W. Karanian, T. Shingu, and N. Salem Jr. 1990. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain homogenate. Prostaglandins. 40:473–490.
- Rowley, A.F., H. Kühn, and T. Schewe, editors. 1998. Eicosanoids and Related Compounds in Plants and Animals. Portland Press, London. 240 pp.
- MacLean, C.H., S.J. Newberry, W.A. Mojica, P. Khanna, A.M. Issa, M.J. Suttorp, Y.W. Lim, S.B. Traina, L. Hilton, R. Garland, and S.C. Morton. 2006. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 295:403–415.
- Dwyer, J.H., H. Allayee, K.M. Dwyer, J. Fan, H. Wu, R. Mar, A.J. Lusis, and M. Mehrabian. 2004. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 350:29–37.
- Colomer, R., J.M. Moreno-Nogueira, P.P. García-Luna, P. García-Peris, A. García-de-Lorenzo, A. Zarazaga, L. Quecedo, J. del Llano, L. Usán, and C. Casimiro. 2007. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br. J. Nutr. 97:823–831.
- Serhan, C.N., Y. Lu, S. Hong, and R. Yang. 2007. Mediator lipidomics: search algorithms for eicosanoids, resolvins and protectins. Methods Enzymol. 432:275–317.
Source: PubMed